@my.journey.with.marc's GLP-1 side effects claims, fact-checked

TikTok creator Marc claims he knows the "most common mistakes" that cause GLP-1 side effects like nausea, vomiting, and diarrhea. But without seeing his specific recommendations, we can't verify if his advice matches what clinical trials actually show about managing these drugs.

What does this video actually claim?

Marc promises to reveal the biggest mistakes people make that supposedly cause side effects with Mounjaro (tirzepatide) and Wegovy (semaglutide). The video's framing suggests these side effects are avoidable user errors rather than expected drug reactions.

This sets up a problematic premise. The most common GLP-1 side effects aren't really "mistakes" people make. They're documented pharmacological effects that happen regardless of how perfectly you follow instructions.

The SUSTAIN 1 trial (Sorli et al., Diabetes Care, 2017) found that 44% of people taking 1.0mg semaglutide experienced nausea. That's not because nearly half the participants made mistakes. It's because semaglutide slows gastric emptying.

What does the science actually show about GLP-1 side effects?

GLP-1 receptor agonists cause predictable gastrointestinal side effects through their mechanism of action. They slow how quickly food leaves your stomach and affect areas of the brain that control nausea.

The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) documented side effects with tirzepatide across all dose levels. At 15mg, 31% experienced nausea, 16% had diarrhea, and 12% had vomiting. These rates occurred despite careful dose escalation protocols.

Dose escalation helps reduce side effects but doesn't eliminate them. Most clinical trials start patients at 0.25mg semaglutide or 2.5mg tirzepatide, then increase every four weeks. This gradual approach minimizes but doesn't prevent gastrointestinal issues.

What mistakes do people actually make?

There are real errors that can worsen GLP-1 side effects, though they're not the primary cause. Taking doses too close together or skipping the gradual escalation can increase nausea and vomiting.

Some people also don't adjust their eating patterns. Since GLP-1s slow gastric emptying, eating large meals or high-fat foods can worsen digestive discomfort. Smaller, more frequent meals typically help.

Alcohol can amplify nausea and should be limited, especially during the first few weeks of treatment. Staying hydrated also helps manage side effects, particularly if you're experiencing vomiting or diarrhea.

But let's be clear: even perfect adherence won't eliminate side effects for everyone. The clinical trial data proves this.

What should you actually expect?

Most GLP-1 side effects are temporary and decrease over time. In the STEP 1 trial (Wilding et al., NEJM, 2021), gastrointestinal side effects were most common during the first 20 weeks as doses increased.

About 7% of people in major semaglutide trials discontinued due to side effects. For tirzepatide, discontinuation rates ranged from 4.3% to 8.5% depending on the dose.

If you're experiencing severe side effects, don't just try to optimize your behavior. Talk to your healthcare provider about dose adjustments or alternative medications. Some people need slower escalation schedules or different GLP-1 formulations.

The idea that side effects are primarily user error minimizes legitimate medication reactions and could discourage people from seeking appropriate medical guidance when they need it.